newsfilter
← Latest News
Business Wire·

Merck Begins Tender Offer to Acquire Acceleron Pharma Inc.

Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Acceleron Pharma Inc. (NASDAQ:XLRN). On Sept. 30, 2021, Merck annou